In breast cancer, this K29- and K33-specific DUB binds, deubiquitinates, and stabilizes the enhancer of zeste homologue (EZH2) catalytic component of the gene silencing Polycomb repressive complex 2 (PRC2) to promote growth, resulting in poor prognosis [66]. The gene discussed is EZH2; the disease is breast cancer.